Article: VITAL THERAPIES INITIATES LIVER STABILIZATION TRIAL.

(Full text of statement. Contact details below.)

MEDIA RELEASE PR36386

Vital Therapies Initiates Liver Stabilization Trial

SAN DIEGO, Oct. 2 /PRNewswire-AsiaNet/ --

Pivotal ELAD Study in United States and Europe

Vital Therapies, Inc. (VTI), today announced that the first subject has been enrolled in a pivotal trial of its ELAD human cell-based liver assist system at California Pacific Medical Center (CPMC) in San Francisco. Todd Frederick, MD, Director of Liver Support Services, is the principal investigator for the trial at CPMC.

It is anticipated that up to 20 leading academic liver centers in the United States and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!